Literature DB >> 18513144

Amyloid, hyperactivity, and metabolism: theoretical comment on Vloeberghs et al. (2008).

Dave Morgan1, Marcia N Gordon.   

Abstract

Recent data suggest that amyloid precursor protein transgenic mice consume excess calories relative to nontransgenic mice, yet they weigh less. Potential explanations include increased locomotor activity or increased basal metabolism. Mechanisms that might underlie the latter explanation include transmembrane pores produced by assemblies of A beta modifying proton or ion gradients across membranes. Alzheimer's disease also results in weight loss. If amyloid were found to induce a hypermetabolic state, this would suggest an alternative mechanism for the pathology found in the disease and provide opportunities for therapeutic strategies not yet considered. (Copyright) 2008 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513144      PMCID: PMC2706527          DOI: 10.1037/0735-7044.122.3.730

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  35 in total

1.  Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity.

Authors:  R Bhatia; H Lin; R Lal
Journal:  FASEB J       Date:  2000-06       Impact factor: 5.191

Review 2.  Metabolic alterations in sepsis and vasoactive drug-related metabolic effects.

Authors:  Karl Träger; Daniel DeBacker; Peter Radermacher
Journal:  Curr Opin Crit Care       Date:  2003-08       Impact factor: 3.687

3.  Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits.

Authors:  L A Holcomb; M N Gordon; P Jantzen; K Hsiao; K Duff; D Morgan
Journal:  Behav Genet       Date:  1999-05       Impact factor: 2.805

4.  Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein.

Authors:  J C Dodart; H Meziane; C Mathis; K R Bales; S M Paul; A Ungerer
Journal:  Behav Neurosci       Date:  1999-10       Impact factor: 1.912

Review 5.  Dietary intake, resting energy expenditure, weight loss and survival in cancer patients.

Authors:  Ingvar Bosaeus; Peter Daneryd; Kent Lundholm
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

6.  Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease.

Authors:  W A Pedersen; C Culmsee; D Ziegler; J P Herman; M P Mattson
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

7.  BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease.

Authors:  Masuo Ohno; Evgeny A Sametsky; Linda H Younkin; Holly Oakley; Steven G Younkin; Martin Citron; Robert Vassar; John F Disterhoft
Journal:  Neuron       Date:  2004-01-08       Impact factor: 17.173

8.  FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.

Authors:  Dorothy G Flood; Andrew G Reaume; Karen S Dorfman; Yin Guo Lin; Diane M Lang; Stephen P Trusko; Mary J Savage; Wim G Annaert; Bart De Strooper; Robert Siman; Richard W Scott
Journal:  Neurobiol Aging       Date:  2002 May-Jun       Impact factor: 4.673

Review 9.  Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.

Authors:  Hani Atamna; William H Frey
Journal:  Mitochondrion       Date:  2007-06-13       Impact factor: 4.160

10.  A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects.

Authors:  Heidi K White; Eleanor S McConnell; Connie W Bales; Maragatha Kuchibhatla
Journal:  J Am Med Dir Assoc       Date:  2004 Mar-Apr       Impact factor: 4.669

View more
  8 in total

1.  Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease.

Authors:  Michael Ewers; Susanne Schmitz; Oskar Hansson; Cathal Walsh; Annette Fitzpatrick; David Bennett; Lennart Minthon; John Q Trojanowski; Leslie M Shaw; Yetunde O Faluyi; Bruno Vellas; Bruno Dubois; Kaj Blennow; Katharina Buerger; Stefan J Teipel; Michael Weiner; Harald Hampel
Journal:  Neurobiol Aging       Date:  2011-06-17       Impact factor: 4.673

2.  Dietary composition affects the development of cognitive deficits in WT and Tg AD model mice.

Authors:  Inga Kadish; Ashish Kumar; Ulrika Beitnere; Emily Jennings; William McGilberry; Thomas van Groen
Journal:  Exp Gerontol       Date:  2016-05-07       Impact factor: 4.032

3.  Novel Detox Gel Depot sequesters β-Amyloid Peptides in a mouse model of Alzheimer's Disease.

Authors:  Ranjini K Sundaram; Chinnaswamy Kasinathan; Stanley Stein; Pazhani Sundaram
Journal:  Int J Pept Res Ther       Date:  2012-06-01       Impact factor: 1.931

4.  Metabolic changes over the course of aging in a mouse model of tau deposition.

Authors:  Aurélie Joly-Amado; Karisa S Serraneau; Milene Brownlow; Caralina Marín de Evsikova; John R Speakman; Marcia N Gordon; Dave Morgan
Journal:  Neurobiol Aging       Date:  2016-04-25       Impact factor: 4.673

5.  Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease.

Authors:  Stephan Müller; Oliver Preische; Hamid R Sohrabi; Susanne Gräber; Mathias Jucker; Janko Dietzsch; John M Ringman; Ralph N Martins; Eric McDade; Peter R Schofield; Bernardino Ghetti; Martin Rossor; Neill R Graff-Radford; Johannes Levin; Douglas Galasko; Kimberly A Quaid; Stephen Salloway; Chengjie Xiong; Tammie Benzinger; Virginia Buckles; Colin L Masters; Reisa Sperling; Randall J Bateman; John C Morris; Christoph Laske
Journal:  Sci Rep       Date:  2017-04-27       Impact factor: 4.379

Review 6.  Cachexia and advanced dementia.

Authors:  Cecilia Minaglia; Chiara Giannotti; Virginia Boccardi; Patrizia Mecocci; Gianluca Serafini; Patrizio Odetti; Fiammetta Monacelli
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-02-22       Impact factor: 12.910

7.  Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer's pathology.

Authors:  Milene L Brownlow; Leif Benner; Dominic D'Agostino; Marcia N Gordon; Dave Morgan
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

8.  Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer's disease.

Authors:  Ewa Kloskowska; Therese M Pham; Tatjana Nilsson; Shunwei Zhu; Johanna Oberg; Alina Codita; Lars A Pedersen; Jan T Pedersen; Katarzyna Malkiewicz; Bengt Winblad; Ronnie Folkesson; Eirikur Benedikz
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.